{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:38:11Z","timestamp":1785209891930,"version":"3.55.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00109-020-01917-8","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:02:27Z","timestamp":1588816947000},"page":"775-787","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target"],"prefix":"10.1007","volume":"98","author":[{"given":"Didem","family":"Karakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1190-9255","authenticated-orcid":false,"given":"Bulent","family":"Ozpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10495-013-0927-2","volume":"19","author":"AA Ashour","year":"2014","unstructured":"Ashour AA, Abdel-Aziz AA, Mansour AM, Alpay SN, Huo L, Ozpolat B (2014a) Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. Apoptosis 19:241\u2013258","journal-title":"Apoptosis"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"11641","DOI":"10.18632\/oncotarget.14264","volume":"8","author":"R Bayraktar","year":"2017","unstructured":"Bayraktar R, Pichler M, Kanlikilicer P, Ivan C, Bayraktar E, Kahraman N, Aslan B, Oguztuzun S, Ulasli M, Arslan A, Calin G, Lopez-Berestein G, Ozpolat B (2017) MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase. Oncotarget 8:11641\u201311658","journal-title":"Oncotarget"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.lungcan.2018.07.027","volume":"124","author":"HA Bircan","year":"2018","unstructured":"Bircan HA, Gurbuz N, Pataer A, Caner A, Kahraman N, Bayraktar E, Bayraktar R, Erdogan MA, Kabil N, Ozpolat B (2018) Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer. Lung Cancer 124:31\u201339","journal-title":"Lung Cancer"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2013.04.055","volume":"153","author":"G Leprivier","year":"2013","unstructured":"Leprivier G, Remke M, Rotblat B, Dubuc A, Mateo AR, Kool M, Agnihotri S, El-Naggar A, Yu B, Somasekharan SP, Faubert B, Bridon G, Tognon CE, Mathers J, Thomas R, Li A, Barokas A, Kwok B, Bowden M, Smith S, Wu X, Korshunov A, Hielscher T, Northcott PA, Galpin JD, Ahern CA, Wang Y, McCabe MG, Collins VP, Jones RG, Pollak M, Delattre O, Gleave ME, Jan E, Pfister SM, Proud CG, Derry WB, Taylor MD, Sorensen PH (2013) The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153:1064\u20131079","journal-title":"Cell"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.radonc.2017.04.001","volume":"124","author":"H Zhu","year":"2017","unstructured":"Zhu H, Song H, Chen G, Yang X, Liu J, Ge Y, Lu J, Qin Q, Zhang C, Xu L, Di X, Cai J, Ma J, Zhang S, Sun X (2017) eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma. Radiother Oncol 124:439\u2013447","journal-title":"Radiother Oncol"},{"key":"1917_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/334170a0","volume":"334","author":"AG Ryazanov","year":"1988","unstructured":"Ryazanov AG, Shestakova EA, Natapov P (1988) Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 334:170\u2013173","journal-title":"Nature"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1016\/S0960-9822(99)80006-2","volume":"9","author":"AG Ryazanov","year":"1999","unstructured":"Ryazanov AG, Pavur KS, Dorovkov MV (1999) Alpha kinases: a new class of protein kinases with a novel catalytic domain. Curr Biol 9:R43\u2013R45","journal-title":"Curr Biol"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jbior.2014.04.003","volume":"55","author":"JW Kenney","year":"2014","unstructured":"Kenney JW, Moore CE, Wang X, Proud CG (2014) Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. Adv Biol Regul 55:15\u201327","journal-title":"Adv Biol Regul"},{"key":"1917_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/aps.2015.123","volume":"37","author":"R Liu","year":"2016","unstructured":"Liu R, Proud CG (2016) Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases. Acta Pharmacol Sin 37:285\u2013294","journal-title":"Acta Pharmacol Sin"},{"key":"1917_CR10","volume-title":"The molecular and cellular biology of aging","author":"N Tavernarakis","year":"2013","unstructured":"Tavernarakis N (2013) Protein synthesis. In: Vijg J, Campisi J, Lithgow G (eds) The molecular and cellular biology of aging. Gerontological Society of America (GSA) Press, Washington DC"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/cancers9120162","volume":"9","author":"X Wang","year":"2017","unstructured":"Wang X, Xie J, Proud CG (2017) Eukaryotic elongation factor 2 kinase (eEF2K) in cancer. Cancers (Basel) 9:162","journal-title":"Cancers (Basel)"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1128\/MCB.01457-14","volume":"35","author":"CE Moore","year":"2015","unstructured":"Moore CE, Mikolajek H, Regufe da Mota S, Wang X, Kenney JW, Werner JM, Proud CG (2015) Elongation factor 2 kinase is regulated by proline hydroxylation and protects cells during hypoxia. Mol Cell Biol 35:1788\u20131804","journal-title":"Mol Cell Biol"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cellsig.2016.10.006","volume":"29","author":"MB Lazarus","year":"2017","unstructured":"Lazarus MB, Levin RS, Shokat KM (2017) Discovery of new substrates of the elongation factor-2 kinase suggests a broader role in the cellular nutrient response. Cell Signal 29:78\u201383","journal-title":"Cell Signal"},{"key":"1917_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molcel.2009.09.025","volume":"36","author":"M Kong","year":"2009","unstructured":"Kong M, Ditsworth D, Lindsten T, Thompson CB (2009) Alpha4 is an essential regulator of PP2A phosphatase activity. Mol Cell 36:51\u201360","journal-title":"Mol Cell"},{"key":"1917_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.molcel.2013.02.008","volume":"50","author":"MA Reid","year":"2013","unstructured":"Reid MA, Wang WI, Rosales KR, Welliver MX, Pan M, Kong M (2013) The B. 55alpha subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol Cell 50:200\u2013211","journal-title":"Mol Cell"},{"key":"1917_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016\u20131023","journal-title":"Nat Cell Biol"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2015","unstructured":"Hardie DG, Schaffer BE, Brunet A (2015) AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol 26:190\u2013201","journal-title":"Trends Cell Biol"},{"key":"1917_CR18","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1128\/MCB.00388-14","volume":"34","author":"CE Moore","year":"2014","unstructured":"Moore CE, Regufe da Mota S, Mikolajek H, Proud CG (2014) A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity. Mol Cell Biol 34:2294\u20132307","journal-title":"Mol Cell Biol"},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1042\/BST20140323","volume":"43","author":"CG Proud","year":"2015","unstructured":"Proud CG (2015) Regulation and roles of elongation factor 2 kinase. Biochem Soc Trans 43:328\u2013332","journal-title":"Biochem Soc Trans"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-5793(87)80081-9","volume":"214","author":"AG Ryazanov","year":"1987","unstructured":"Ryazanov AG (1987) Ca2+\/calmodulin-dependent phosphorylation of elongation factor 2. FEBS Lett 214:331\u2013334","journal-title":"FEBS Lett"},{"key":"1917_CR21","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.str.2016.06.015","volume":"24","author":"K Lee","year":"2016","unstructured":"Lee K, Alphonse S, Piserchio A, Tavares CD, Giles DH, Wellmann RM, Dalby KN, Ghose R (2016) Structural basis for the recognition of eukaryotic elongation factor 2 kinase by calmodulin. Structure 24:1441\u20131451","journal-title":"Structure"},{"key":"1917_CR22","first-page":"218","volume":"7","author":"S Kameshima","year":"2016","unstructured":"Kameshima S, Okada M, Ikeda S, Watanabe Y, Yamawaki H (2016) Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes. Biochem Biophys Rep 7:218\u2013224","journal-title":"Biochem Biophys Rep"},{"key":"1917_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-5793(99)01034-0","volume":"457","author":"TA Diggle","year":"1999","unstructured":"Diggle TA, Seehra CK, Hase S, Redpath NT (1999) Analysis of the domain structure of elongation factor-2 kinase by mutagenesis. FEBS Lett 457:189\u2013192","journal-title":"FEBS Lett"},{"key":"1917_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/BJ20111536","volume":"442","author":"CR Pigott","year":"2011","unstructured":"Pigott CR, Mikolajek H, Moor E, Finn SJ, Phippe CW, Werner JM, Proud CG (2011) Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains. Biochem J 442:105\u2013118","journal-title":"Biochem J"},{"key":"1917_CR25","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1021\/bi201788e","volume":"51","author":"CDJ Tavares","year":"2012","unstructured":"Tavares CDJ, O\u2019Brien JP, Abramczyk O, Devkota AK, Shores KS, Ozpolat B, Dalby K (2012) Calcium\/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence. Biochemistry 51:2232\u20132245","journal-title":"Biochemistry"},{"key":"1917_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/BJ20111530","volume":"442","author":"S Pyr Dit Ruys","year":"2012","unstructured":"Pyr Dit Ruys S, Wang X, Smith EM, Herinckx G, Hussain N, Rider MH, Vertommen D, Proud CG (2012) Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase. Biochem J 442:681\u2013692","journal-title":"Biochem J"},{"key":"1917_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2013.01.004","volume":"38","author":"JL Jewell","year":"2013","unstructured":"Jewell JL, Guan KL (2013) Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 38:233\u2013242","journal-title":"Trends Biochem Sci"},{"key":"1917_CR28","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/j.1460-2075.1996.tb00582.x","volume":"15","author":"NT Redpath","year":"1996","unstructured":"Redpath NT, Foulstone EJ, Proud CG (1996) Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J 15:2291\u20132297","journal-title":"EMBO J"},{"key":"1917_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj3530621","volume":"353","author":"TA Diggle","year":"2001","unstructured":"Diggle TA, Subkhankulova T, Lilley KS, Shikotra N, Willis AE, Redpath NT (2001) Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+\/ calmodulin-independent activity. Biochem J 353:621\u2013626","journal-title":"Biochem J"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1042\/BST20130036","volume":"41","author":"CG Proud","year":"2013","unstructured":"Proud CG (2013) mTORC1 regulates the efficiency and cellular capacity for protein synthesis. Biochem Soc Trans 41:923\u2013926","journal-title":"Biochem Soc Trans"},{"key":"1917_CR31","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1128\/MCB.01035-14","volume":"34","author":"X Wang","year":"2014","unstructured":"Wang X, Regufe da Mota S, Liu R, Moore CE, Xie J, Lanucara F, Agarwala U, Pyr Dit Ruys S, Vertommen D, Rider MH, Eyers CE, Proud CG (2014a) Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling. Mol Cell Biol 34:4088\u20134103","journal-title":"Mol Cell Biol"},{"key":"1917_CR32","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1093\/emboj\/20.16.4370","volume":"20","author":"X Wang","year":"2001","unstructured":"Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG (2001) Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J 20:4370\u20134379","journal-title":"EMBO J"},{"key":"1917_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","volume":"34","author":"DG Hardie","year":"2014","unstructured":"Hardie DG (2014) AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels. Annu Rev Nutr 34:31\u201355","journal-title":"Annu Rev Nutr"},{"key":"1917_CR34","doi-asserted-by":"publisher","first-page":"12220","DOI":"10.1074\/jbc.M309773200","volume":"279","author":"GJ Browne","year":"2004","unstructured":"Browne GJ, Finn SG, Proud CG (2004) Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J Biol Chem 279:12220\u201312231","journal-title":"J Biol Chem"},{"key":"1917_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cellsig.2017.05.010","volume":"36","author":"M Johanns","year":"2017","unstructured":"Johanns M, Ruys SPD, Houddane A, Vertommen D, Herinckx G, Hue L, Proud CG, Rider MH (2017) Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase. Cell Signal 36:212\u2013221","journal-title":"Cell Signal"},{"key":"1917_CR36","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.bbagrm.2014.09.016","volume":"1839","author":"S Zona","year":"2014","unstructured":"Zona S, Bella L, Burton MJ, Nestal de Moraes G, Lam EW (2014) FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim Biophys Acta 1839:1316\u20131322","journal-title":"Biochim Biophys Acta"},{"key":"1917_CR37","doi-asserted-by":"publisher","first-page":"16619","DOI":"10.18632\/oncotarget.7672","volume":"7","author":"Z Hamurcu","year":"2016","unstructured":"Hamurcu Z, Ashour A, Kahraman N, Ozpolat B (2016) FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Oncotarget 7:16619\u201316635","journal-title":"Oncotarget"},{"key":"1917_CR38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"1917_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profiles classify human cancers. Nature 435:834\u2013838","journal-title":"Nature"},{"key":"1917_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach H, Nishida N, Calin GA, Pantel K (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11:145\u2013156","journal-title":"Nat Rev Clin Oncol"},{"key":"1917_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259\u2013269","journal-title":"Nat Rev Cancer"},{"key":"1917_CR42","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1261\/rna.2248605","volume":"11","author":"RS Pillai","year":"2005","unstructured":"Pillai RS (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11:1753\u20131761","journal-title":"RNA"},{"key":"1917_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1479-5876-10-228","volume":"10","author":"B Chen","year":"2012","unstructured":"Chen B, Li H, Zeng X, Yang P, Liu X, Zhao X, Liang S (2012) Roles of microRNA on cancer cell metabolism. J Transl Med 10:228","journal-title":"J Transl Med"},{"key":"1917_CR44","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-17-1959","volume":"24","author":"R Bayraktar","year":"2018","unstructured":"Bayraktar R, Ivan C, Bayraktar E, Kanlikilicer P, Kabil NN, Kahraman N, Mokhlis HA, Karakas D, Rodriguez-Aguayo C, Arslan A, Sheng J, Wong S, Lopez-Berestein G, Calin GA, Ozpolat B (2018) Dual suppressive effect of miR-34a on the FOXM1\/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion. Clin Cancer Res 24:4225\u20134241","journal-title":"Clin Cancer Res"},{"key":"1917_CR45","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3892\/ol.2015.4072","volume":"11","author":"Q Shi","year":"2016","unstructured":"Shi Q, Xu X, Liu Q, Luo F, Shi J, He X (2016) MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncol Lett 11:1474\u20131480","journal-title":"Oncol Lett"},{"key":"1917_CR46","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1158\/0008-5472.CAN-08-2872","volume":"69","author":"H Wu","year":"2009","unstructured":"Wu H, Zhu H, Liu DX, Niu TK, Ren X, Patel R, Hait WN, Yang JM (2009) Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res 69:2453\u20132460","journal-title":"Cancer Res"},{"key":"1917_CR47","doi-asserted-by":"publisher","first-page":"e41171","DOI":"10.1371\/journal.pone.0041171","volume":"7","author":"I Tekedereli","year":"2012","unstructured":"Tekedereli I, Alpay SN, Tavares CD, Cobanoglu ZE, Kaoud TS, Sahin I, Sood AK, Lopez-Berestein G, Dalby KN, Ozpolat B (2012) Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One 7:e41171","journal-title":"PLoS One"},{"key":"1917_CR48","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1111\/jcmm.12361","volume":"18","author":"AA Ashour","year":"2014","unstructured":"Ashour AA, Gurbuz N, Alpay SN, Abdel-Aziz AA, Mansour AM, Huo L, Ozpolat B (2014b) Elongation factor-2 kinase regulates TG2\/\u03b21 integrin\/Src\/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion. J Cell Mol Med 18:2235\u20132251","journal-title":"J Cell Mol Med"},{"key":"1917_CR49","first-page":"2756","volume":"5","author":"L Huang","year":"2015","unstructured":"Huang L, Xu AM, Liu W (2015) Transglutaminase 2 in cancer. Am J Cancer Res 5:2756\u20132776","journal-title":"Am J Cancer Res"},{"key":"1917_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1158\/1541-7786.MCR-06-0229","volume":"5","author":"U Akar","year":"2007","unstructured":"Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, Lopez-Berestein G (2007) Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res 5:241\u2013249","journal-title":"Mol Cancer Res"},{"key":"1917_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbrc.2011.09.038","volume":"414","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Cheng Y, Zhang L, Ren X, Huber-Keener KJ, Lee S, Yun J, Wang HG, Yang JM (2011) Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression. Biochem Biophys Res Commun 414:129\u2013134","journal-title":"Biochem Biophys Res Commun"},{"key":"1917_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43:67\u201393","journal-title":"Annu Rev Genet"},{"key":"1917_CR53","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cdd.2014.150","volume":"22","author":"G Filomeni","year":"2015","unstructured":"Filomeni G, De Zio D, Cecconi F (2015) Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ 22:377\u2013388","journal-title":"Cell Death Differ"},{"key":"1917_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00432-017-2557-5","volume":"144","author":"Z Hamurcu","year":"2018","unstructured":"Hamurcu Z, Deliba\u015f\u0131 N, Ge\u00e7ene S, \u015eener EF, D\u00f6nmez-Altunta\u015f H, \u00d6zkul Y, Canatan H, Ozpolat B (2018) Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR\/Integrin \u03b21\/Src signaling in triple negative breast cancer cells. J Cancer Res Clin Oncol 144:415\u2013430","journal-title":"J Cancer Res Clin Oncol"},{"key":"1917_CR55","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.4161\/auto.29164","volume":"10","author":"CM Xie","year":"2014","unstructured":"Xie CM, Liu XY, Sham KW, Lai JM, Cheng CH (2014) Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells. Autophagy 10:1495\u20131508","journal-title":"Autophagy"},{"key":"1917_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274\u2013293","journal-title":"Cell"},{"key":"1917_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol 15:155\u2013162","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1917_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/cr.2015.146","volume":"26","author":"M Shimobayashi","year":"2016","unstructured":"Shimobayashi M, Hall MN (2016) Multiple amino acid sensing inputs to mTORC1. Cell Res 26:7\u201320","journal-title":"Cell Res"},{"key":"1917_CR59","doi-asserted-by":"publisher","first-page":"e970489","DOI":"10.4161\/23723548.2014.970489","volume":"2","author":"AM Heberle","year":"2015","unstructured":"Heberle AM, Prentzell MT, van Eunen K, Bakker BM, Grellscheid SN, Thedieck K (2015) Molecular mechanisms of mTOR regulation by stress. Mol Cell Oncol 2:e970489","journal-title":"Mol Cell Oncol"},{"key":"1917_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4161\/auto.7.6.15123","volume":"7","author":"D Egan","year":"2011","unstructured":"Egan D, Kim J, Shaw R, Guan KL (2011) The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7:643\u2013644","journal-title":"Autophagy"},{"key":"1917_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.gde.2017.11.003","volume":"48","author":"LM Lindqvist","year":"2018","unstructured":"Lindqvist LM, Tandoc K, Topisirovic I, Furic L (2018) Cross-talk between protein synthesis, energy metabolism and autophagy in cancer. Curr Opin Genet Dev 48:104\u2013111","journal-title":"Curr Opin Genet Dev"},{"key":"1917_CR62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/EBC20170027","volume":"61","author":"Y Rabanal-Ruiz","year":"2017","unstructured":"Rabanal-Ruiz Y, Otten EG, Korolchuk VI (2017) mTORC1 as the main gateway to autophagy. Essays Biochem 61:565\u2013584","journal-title":"Essays Biochem"},{"key":"1917_CR63","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408398.2010.500245","volume":"52","author":"J Xu","year":"2012","unstructured":"Xu J, Ji J, Yan XH (2012) Cross-talk between AMPK and mTOR in regulating energy balance. Crit Rev Food Sci Nutr 52:373\u2013381","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1917_CR64","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132\u2013141","journal-title":"Nat Cell Biol"},{"key":"1917_CR65","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1158\/0008-5472.CAN-05-1554","volume":"66","author":"H Wu","year":"2006","unstructured":"Wu H, Yang JM, Jin S, Zhang H, Hait WN (2006) Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 66:3015\u20133023","journal-title":"Cancer Res"},{"key":"1917_CR66","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4161\/auto.22801","volume":"9","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Ren X, Zhang Y, Shan Y, Huber-Keener KJ, Zhang L, Kimball SR, Harvey H, Jefferson LS, Yang JM (2013) Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells. Autophagy 9:208\u2013219","journal-title":"Autophagy"},{"key":"1917_CR67","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41598-017-01207-3","volume":"7","author":"JA Pinto","year":"2017","unstructured":"Pinto JA, Rolfo C, Raez LE, Prado A, Araujo JM, Bravo L, Fajardo W, Morante ZD, Aguilar A, Neciosup SP, Mas LA, Bretel D, Balko JM, Gomez HL (2017) In silico evaluation of DNA damage inducible transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Sci Rep 7:1526","journal-title":"Sci Rep"},{"key":"1917_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12402","volume":"51","author":"D Sun","year":"2018","unstructured":"Sun D, Zhu L, Zhao Y, Jiang Y, Chen L, Yu Y, Ouyang L (2018) Fluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancer. Cell Prolif 51:e12402","journal-title":"Cell Prolif"},{"key":"1917_CR69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cellsig.2016.01.005","volume":"28","author":"CE Moore","year":"2016","unstructured":"Moore CE, Wang X, Xie J, Pickford J, Barron J, Regufe da Mota S, Versele M, Proud CG (2016) Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy. Cell Signal 28:284\u2013293","journal-title":"Cell Signal"},{"key":"1917_CR70","doi-asserted-by":"publisher","unstructured":"Karakas D, Kahraman N, Bayraktar R, Kabil N, Ulukaya E, Dere E, Lopez-Berestein G, Ozpolat B (2018) Identification of microenvironmental regulation and therapeutic targeting of ongenic EF-2 kinase in pancreatic cancer. (Conference paper). Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam. doi: https:\/\/doi.org\/10.1136\/esmoopen-2018-EACR25.803","DOI":"10.1136\/esmoopen-2018-EACR25.803"},{"key":"1917_CR71","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/ijc.31210","volume":"142","author":"J Xie","year":"2018","unstructured":"Xie J, Shen K, Lenchine RV, Gethings LA, Trim PJ, Snel MF, Zhou Y, Kenney JW, Kamei M, Kochetkova M, Wang X, Proud CG (2018) Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. Int J Cancer 142:1865\u20131877","journal-title":"Int J Cancer"},{"key":"1917_CR72","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/ijc.32560","volume":"146","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Li Y, Xu S, Lu J, Zhu Z, Chen S, Tan Y, He P, Xu J, Proud CG, Xie J, Shen K (2019) Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K\/Akt and STAT3. Int J Cancer 146:1383\u20131395","journal-title":"Int J Cancer"},{"issue":"13 Supplement","key":"1917_CR73","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/1538-7445.AM2017-1125","volume":"77","author":"E Asik","year":"2017","unstructured":"Asik E, Kahraman N, Guray T, Volkan M, Lopez-Berestein G, Ozpolat B (2017) Eukaryotic elongation factor 2 kinase (eEF-2K) is a novel therapeutic target in BRCA1+ mutated breast cancer. (Conference paper). Cancer Res 77(13 Supplement):1125\u20131125","journal-title":"Cancer Res"},{"key":"1917_CR74","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-10-2889","volume":"71","author":"Y Cheng","year":"2011","unstructured":"Cheng Y, Ren X, Zhang Y, Patel R, Sharma A, Wu H, Robertson GP, Yan L, Rubin E, Yang JM (2011) eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 71:2654\u20132663","journal-title":"Cancer Res"},{"key":"1917_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368:7\u201313","journal-title":"Cancer Lett"},{"key":"1917_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi Y, Hu G, Sun Y (2015) New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13:45","journal-title":"BMC Med"},{"key":"1917_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0065-230X(08)00007-9","volume":"100","author":"IP Witz","year":"2008","unstructured":"Witz IP (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100:203\u2013229","journal-title":"Adv Cancer Res"},{"key":"1917_CR78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s13238-010-0102-2","volume":"1","author":"LY Li","year":"2010","unstructured":"Li LY (2010) Tumor microenvironment: bidirectional interactions between cancer cells and normal cells. Protein Cell 1:702\u2013705","journal-title":"Protein Cell"},{"key":"1917_CR79","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125:5591\u20135596","journal-title":"J Cell Sci"},{"key":"1917_CR80","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437","journal-title":"Nat Med"},{"key":"1917_CR81","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21:309\u2013322","journal-title":"Cancer Cell"},{"key":"1917_CR82","doi-asserted-by":"publisher","first-page":"15025","DOI":"10.1038\/npjbcancer.2015.25","volume":"2","author":"CB Williams","year":"2016","unstructured":"Williams CB, Yeh ES, Soloff AC (2016) Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer 2:15025","journal-title":"NPJ Breast Cancer"},{"key":"1917_CR83","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00018-016-2346-3","volume":"74","author":"Y Naito","year":"2017","unstructured":"Naito Y, Yoshioka Y, Yamamoto Y, Ochiya T (2017) How cancer cells dictate their microenvironment: present roles of extracellular vesicles. Cell Mol Life Sci 74:697\u2013713","journal-title":"Cell Mol Life Sci"},{"key":"1917_CR84","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCRESAHA.117.311973","volume":"121","author":"JE Kanter","year":"2017","unstructured":"Kanter JE (2017) Monocyte recruitment versus macrophage proliferation in atherosclerosis. Circ Res 121:1109\u20131110","journal-title":"Circ Res"},{"key":"1917_CR85","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","volume":"13","author":"A Mantovani","year":"1992","unstructured":"Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265\u2013270","journal-title":"Immunol Today"},{"key":"1917_CR86","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416","journal-title":"Nat Rev Clin Oncol"},{"key":"1917_CR87","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:889\u2013896","journal-title":"Nat Immunol"},{"key":"1917_CR88","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/cas.12964","volume":"107","author":"W Tian","year":"2016","unstructured":"Tian W, Wang L, Yuan L, Duan W, Zhao W, Wang S, Zhang Q (2016) A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6. Cancer Sci 107:882\u2013889","journal-title":"Cancer Sci"},{"key":"1917_CR89","doi-asserted-by":"publisher","first-page":"49349","DOI":"10.18632\/oncotarget.9885","volume":"7","author":"WB Fang","year":"2016","unstructured":"Fang WB, Yao M, Brummer G, Acevedo D, Alhakamy N, Berkland C, Cheng N (2016) Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment. Oncotarget 7:49349\u201349367","journal-title":"Oncotarget"},{"key":"1917_CR90","first-page":"3876","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang H, Zhang Q, Kong H, Zeng Y, Hao M, Yu T, Peng J, Xu Z, Chen J, Shi H (2014b) Monocyte chemotactic protein-1 expression as a prognosic biomarker in patients with solid tumor: a meta analysis. Int J Clin Exp Pathol 7:3876\u20133886","journal-title":"Int J Clin Exp Pathol"},{"key":"1917_CR91","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20141836","volume":"212","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, Kato Y, Li J, Pollard JW (2015) CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med 212:1043\u20131059","journal-title":"J Exp Med"},{"key":"1917_CR92","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","volume":"73","author":"JB Mitchem","year":"2013","unstructured":"Mitchem JB, Brennan DJ, Knolhoff BL, Belt BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D, Hewitt S, Udupi GM, Gallagher WM, Wegner C, West BL, Wang-Gillam A, Goedegebuure P, Linehan DC, DeNardo DG (2013) Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res 73:1128\u20131141","journal-title":"Cancer Res"},{"key":"1917_CR93","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/ATVBAHA.108.174599","volume":"29","author":"JH Chen","year":"2009","unstructured":"Chen JH, Riazy M, Smith EM, Proud CG, Steinbrecher UP, Duronio V (2009) Oxidized LDL-mediated macrophage survival involves elongation factor-2 kinase. Arterioscler Thromb Vasc Biol 29:92\u201398","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1917_CR94","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.cjca.2014.09.019","volume":"30","author":"P Zhang","year":"2014","unstructured":"Zhang P, Riazy M, Gold M, Tsai SH, McNagny K, Proud C, Duronio V (2014) Impairing eukaryotic elongation factor 2 kinase activity decreases atherosclerotic plaque formation. Can J Cardiol 30:1684\u20131688","journal-title":"Can J Cardiol"},{"key":"1917_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12885-016-2288-z","volume":"16","author":"Z Xu","year":"2016","unstructured":"Xu Z, Zhao L, Yang X, Ma S, Ge Y, Liu Y, Liu S, Shi J, Zheng D (2016) Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2. BMC Cancer 16:252","journal-title":"BMC Cancer"},{"key":"1917_CR96","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ol.2013.1168","volume":"5","author":"S Li","year":"2013","unstructured":"Li S, Sun Y, Gao D (2013) Role of the nervous system in cancer metastasis. Oncol Lett 5:1101\u20131111","journal-title":"Oncol Lett"},{"key":"1917_CR97","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/mpa.0b013e3180619677","volume":"35","author":"M Kayahara","year":"2007","unstructured":"Kayahara M, Nakagawara H, Kitagawa H, Ohta T (2007) The nature of neural invasion by pancreatic cancer. Pancreas 35:218\u2013223","journal-title":"Pancreas"},{"key":"1917_CR98","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s004280100496","volume":"440","author":"P Seifert","year":"2002","unstructured":"Seifert P, Benedic M, Effert P (2002) Nerve fibers in tumors of the human urinary bladder. Virchows Arch 440:291\u2013297","journal-title":"Virchows Arch"},{"key":"1917_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0163-7258(02)00174-2","volume":"94","author":"S Ventura","year":"2002","unstructured":"Ventura S, Pennefather J, Mitchelson F (2002) Cholinergic innervation and function in the prostate gland. Pharmacol Ther 94:93\u2013112","journal-title":"Pharmacol Ther"},{"key":"1917_CR100","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0959-8049(94)90465-0","volume":"30A","author":"BS Mitchell","year":"1994","unstructured":"Mitchell BS, Schumacher U, Stauber VV, Kaiserling E (1994) Are breast tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign and malignant breast lesions. Eur J Cancer 30A:1100\u20131103","journal-title":"Eur J Cancer"},{"key":"1917_CR101","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9394(02)01329-6","volume":"133","author":"P Seifert","year":"2002","unstructured":"Seifert P, Spitznas M (2002) Axons in human choroidal melanoma suggest the participation of nerves in the control of these tumors. Am J Ophthalmol 133:711\u2013713","journal-title":"Am J Ophthalmol"},{"key":"1917_CR102","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"P Jobling","year":"2015","unstructured":"Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H (2015) Nerve-cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res 75:1777\u20131781","journal-title":"Cancer Res"},{"key":"1917_CR103","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1128\/MCB.26.10.3955-3965.2006","volume":"26","author":"E Connolly","year":"2006","unstructured":"Connolly E, Braunstein S, Formenti S, Schneider RJ (2006) Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 26:3955\u20133965","journal-title":"Mol Cell Biol"},{"key":"1917_CR104","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/jnc.13407","volume":"136","author":"JW Kenney","year":"2015","unstructured":"Kenney JW, Genheden M, Moon KM, Wang X, Foster LJ, Proud CG (2015) Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule-related proteins in neurons. J Neurochem 136:276\u2013284","journal-title":"J Neurochem"},{"key":"1917_CR105","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10:767\u2013777","journal-title":"Nat Rev Drug Discov"},{"key":"1917_CR106","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1128\/MCB.00012-15","volume":"35","author":"J Xie","year":"2015","unstructured":"Xie J, Mikolajek H, Pigott CR, Hooper KJ, Mellows T, Moore CE, Mohammed H, Werner JM, Thomas GJ, Proud CG (2015) Molecular mechanism for the control of eukaryotic elongation factor 2 kinase by pH: role in cancer cell survival. Mol Cell Biol 35:1805\u20131824","journal-title":"Mol Cell Biol"},{"key":"1917_CR107","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1097-2765(01)00256-8","volume":"7","author":"H Yamaguchi","year":"2001","unstructured":"Yamaguchi H, Matsushita M, Nairn AC, Kuriyan J (2001) Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol Cell 7:1047\u20131057","journal-title":"Mol Cell"},{"key":"1917_CR108","doi-asserted-by":"publisher","first-page":"ra17","DOI":"10.1126\/scisignal.2000525","volume":"3","author":"Q Ye","year":"2010","unstructured":"Ye Q, Crawley SW, Yang Y, Cote GP, Jia Z (2010) Crystal structure of the alpha-kinase domain of dictyostelium myosin heavy chain kinase A. Sci Signal 3:ra17","journal-title":"Sci Signal"},{"key":"1917_CR109","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.15252\/embr.201642194","volume":"17","author":"A De Gassart","year":"2016","unstructured":"De Gassart A, Demaria O, Panes R, Zaffalon L, Ryazanov AG, Gilliet M, Martinon F (2016) Pharmacological eEF2K activation promotes cell death and inhibits cancer progression. EMBO Rep 17:1471\u20131484","journal-title":"EMBO Rep"},{"key":"1917_CR110","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","volume":"199","author":"M Gschwendt","year":"1994","unstructured":"Gschwendt M, M\u00fcller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F (1994a) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199:93\u201398","journal-title":"Biochem Biophys Res Commun"},{"key":"1917_CR111","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-5793(94)80121-5","volume":"338","author":"M Gschwendt","year":"1994","unstructured":"Gschwendt M, Kittstein W, Marks F (1994b) Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Lett 338:85\u201388","journal-title":"FEBS Lett"},{"key":"1917_CR112","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95\u2013105","journal-title":"Biochem J"},{"key":"1917_CR113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0304-4165(00)00061-1","volume":"1475","author":"SI Cho","year":"2000","unstructured":"Cho SI, Koketsu M, Ishihara H, Matsushita M, Nairn AC, Fukazawa H, Uehara Y (2000) Novel compounds, \u20181,3-selenazine derivatives\u2019 as specific inhibitors of eukaryotic elongation factor-2 kinase. Biochim Biophys Acta 1475:207\u2013215","journal-title":"Biochim Biophys Acta"},{"key":"1917_CR114","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1016\/S0968-0896(02)00160-8","volume":"10","author":"H Hori","year":"2002","unstructured":"Hori H, Nagasawa H, Ishibashi M, Uto Y, Hirata A, Saijo K, Ohkura K, Kirk KL, Uehara Y (2002) TX-1123: an antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorg Med Chem 10:3257\u20133265","journal-title":"Bioorg Med Chem"},{"key":"1917_CR115","first-page":"6894","volume":"63","author":"S Arora","year":"2003","unstructured":"Arora S, Yang JM, Kinzy TG, Utsumi R, Okamoto T, Kitayama T, Ortiz PA, Hait WN (2003) Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines. Cancer Res 63:6894\u20136899","journal-title":"Cancer Res"},{"key":"1917_CR116","doi-asserted-by":"publisher","first-page":"43951","DOI":"10.1074\/jbc.M111.301291","volume":"286","author":"Z Chen","year":"2011","unstructured":"Chen Z, Gopalakrishnan SM, Bui MH, Soni NB, Warrior U, Johnson EF, Donnelly JB, Glaser KB (2011) 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem 286:43951\u201343958","journal-title":"J Biol Chem"},{"key":"1917_CR117","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1021\/bi201787p","volume":"51","author":"AK Devkota","year":"2012","unstructured":"Devkota AK, Tavares CD, Warthaka M, Abramczyk O, Marshall KD, Kaoud TS, Gorgulu K, Ozpolat B, Dalby KN (2012) Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Biochemistry 51:2100\u20132112","journal-title":"Biochemistry"},{"key":"1917_CR118","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.bmcl.2010.02.005","volume":"20","author":"JW Lockman","year":"2010","unstructured":"Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal VJ, Willardsen JA (2010) Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues. Bioorg Med Chem Lett 20:2283\u20132286","journal-title":"Bioorg Med Chem Lett"},{"key":"1917_CR119","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ejmech.2017.11.065","volume":"143","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zhao Y, Wang G, Chen Y, Jiang Y, Ouyang L, Liu B (2018) Design, synthesis and structure-activity relationship of a focused library of \u03b2-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer. Eur J Med Chem 143:402\u2013418","journal-title":"Eur J Med Chem"},{"key":"1917_CR120","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature13896","volume":"517","author":"WJ Faller","year":"2015","unstructured":"Faller WJ, Jackson TJ, Knight JR, Ridgway RA, Jamieson T, Karim SA, Jones C, Radulescu S, Huels DJ, Myant KB, Dudek KM, Casey HA, Scopelliti A, Cordero JB, Vidal M, Pende M, Ryazanov AG, Sonenberg N, Meyuhas O, Hall MN, Bushell M, Willis AE, Sansom OJ (2015) mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517:497\u2013500","journal-title":"Nature"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01917-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:17:25Z","timestamp":1666505845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01917-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":120,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01917-8","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}